Protein Nitration in Placenta - Functional Significance

Placenta

Volumn 29, Issue 12, 2008, Pages 985-994

  Webster, R P ^a   Roberts, V H J ^a   Myatt, L ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Nitric oxide; Oxidative stress; Peroxynitrite; Placenta; Superoxide

Indexed keywords

3 NITROTYROSINE; CARBON MONOXIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; PLACENTA PROTEIN; PROSTACYCLIN SYNTHASE; PROSTAGLANDIN SYNTHASE; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; IMMUNOGENICITY; INFLAMMATION; ISCHEMIA; NITRATION; NITRATIVE STRESS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROCESSING; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TROPHOBLAST; UPREGULATION;

ANIMALS; FEMALE; HUMANS; NITRIC OXIDE; PEROXYNITROUS ACID; PLACENTA; PREGNANCY; PREGNANCY PROTEINS; REACTIVE NITROGEN SPECIES; SUPEROXIDES;

EID: 56249113280     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.09.003     Document Type: Article

References (164)

1. Pacher P., Beckman J.S., and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87 (2007) 315-424
2. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci U S A 101 (2004) 4003-4008
3. Cannon III R.O. Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clin Chem 44 (1998) 1809-1819
4. Koppenol W.H. The basic chemistry of nitrogen monoxide and peroxynitrite. Free Radic Biol Med 25 (1998) 385-391
5. Raij L. Nitric oxide in the pathogenesis of cardiac disease. J Clin Hypertens (Greenwich) 8 (2006) 30-39
6. Ghafourifar P., and Sen C.K. Mitochondrial nitric oxide synthase. Front Biosci 12 (2007) 1072-1078
7. Myatt L., Brockman D.E., Langdon G., and Pollock J.S. Constitutive calcium-dependent isoform of nitric oxide synthase in the human placental villous vascular tree. Placenta 14 (1993) 373-383
8. Myatt L., Brockman D.E., Eis A.L., and Pollock J.S. Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta 14 (1993) 487-495
9. Myatt L., Eis A.L., Brockman D.E., Greer I.A., and Lyall F. Endothelial nitric oxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth restricted pregnancies. Hum Reprod 12 (1997) 167-172
10. Lyall F., Greer I.A., Young A., and Myatt L. Nitric oxide concentrations are increased in the feto-placental circulation in intrauterine growth restriction. Placenta 17 (1996) 165-168
11. Lyall F., Young A., and Greer I.A. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol 173 (1995) 714-718
12. Myatt L., Eis A.L., Brockman D.E., Kossenjans W., Greer I., and Lyall F. Inducible (type II) nitric oxide synthase in human placental villous tissue of normotensive, pre-eclamptic and intrauterine growth-restricted pregnancies. Placenta 18 (1997) 261-268
13. Madamanchi N.R., Vendrov A., and Runge M.S. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25 (2005) 29-38
14. Myatt L., and Cui X. Oxidative stress in the placenta. Histochem Cell Biol 122 (2004) 369-382
15. Cui X.-L., Brockman D., Campos B., and Myatt L. Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia. Placenta 27 (2006) 422-431
16. Carreras M.C., and Poderoso J.J. Mitochondrial nitric oxide in the signaling of cell integrated responses. Am J Physiol Cell Physiol 292 (2007) C1569-C1580
17. Beckman J., Ye Y., Anderson P., Chen J., Accqvitti M., Trapey M., et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler 375 (1994) 81-88
18. Haddad I.Y., Pataki G., Hu P., Galliani C., Beckman J.S., and Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 94 (1994) 2407-2413
19. Myatt L., Rosenfield R.B., Eis A.L., Brockman D.E., Greer I., and Lyall F. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension 28 (1996) 488-493
20. Radi R., Peluffo G., Alvarez M.N., Naviliat M., and Cayota A. Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 30 (2001) 463-488
21. Chen Y.R., Chen C.L., Chen W., Zweier J.L., Augusto O., Radi R., et al. Formation of protein tyrosine ortho-semiquinone radical and nitrotyrosine from cytochrome c-derived tyrosyl radical. J Biol Chem (2004)
22. Feelisch M. Nitrated cyclic GMP as a new cellular signal. Nat Chem Biol 3 (2007) 687-688
23. Greenacre S.A., and Ischiropoulos H. Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic Res 34 (2001) 541-581
24. Davidge S.T., Ojimba J., and McLaughlin M.K. Vascular function in the vitamin E-deprived rat: an interaction between nitric oxide and superoxide anions. Hypertension 31 (1998) 830-835
25. Frustaci A., Kajstura J., Chimenti C., Jakoniuk I., Leri A., Maseri A., et al. Myocardial cell death in human diabetes. Circ Res 87 (2000) 1123-1132
26. Kajstura J., Fiordaliso F., Andreoli A.M., Li B., Chimenti S., Medow M.S., et al. IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 50 (2001) 1414-1424
27. Mihm M.J., Coyle C.M., Schanbacher B.L., Weinstein D.M., and Bauer J.A. Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc Res 49 (2001) 798-807
28. Zou M.H., Leist M., and Ullrich V. Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. Am J Pathol 154 (1999) 1359-1365
29. Turko I.V., Marcondes S., and Murad F. Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. Am J Physiol Heart Circ Physiol 281 (2001) H2289-H2294
30. Mihm M.J., Yu F., Carnes C.A., Reiser P.J., McCarthy P.M., Van Wagoner D.R., et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104 (2001) 174-180
31. Nomiyama T., Igarashi Y., Taka H., Mineki R., Uchida T., Ogihara T., et al. Reduction of insulin-stimulated glucose uptake by peroxynitrite is concurrent with tyrosine nitration of insulin receptor substrate-1. Biochem Biophys Res Commun 320 (2004) 639-647
32. Zanelli S.A., Ashraf Q.M., and Mishra O.P. Nitration is a mechanism of regulation of the NMDA receptor function during hypoxia. Neuroscience 112 (2002) 869-877
33. Koeck T., Stuehr D.J., and Aulak K.S. Mitochondria and regulated tyrosine nitration. Biochem Soc Trans 33 (2005) 1399-1403
34. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 356 (1998) 1-11
35. Shishehbor M.H., Aviles R.J., Brennan M.L., Fu X., Goormastic M., Pearce G.L., et al. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 289 (2003) 1675-1680
36. Landino L.M., Crews B.C., Timmons M.D., Morrow J.D., and Marnett L.J. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci U S A 93 (1996) 15069-15074
37. Szabo C., Zingarelli B., O'Connor M., and Salzman A.L. DNA strand breakage, activation of poly(ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci U S A 93 (1996) 1753-1758
38. Gole M.D., Souza J.M., Choi I., Hertkorn C., Malcolm S., Foust III R.F., et al. Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 278 (2000) L961-L967
39. Balafanova Z., Bolli R., Zhang J., Zheng Y., Pass J.M., Bhatnagar A., et al. Nitric oxide (NO) induces nitration of protein kinase cepsilon (PKCepsilon), facilitating PKCepsilon translocation via enhanced PKCepsilon-RACK2 interactions. A novel mechanism of NO-triggered activation of PKC epsilon. J Biol Chem 277 (2002) 15021-15027
40. Peluffo G., and Radi R. Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res 75 (2007) 291-302
41. Cobbs C.S., Samanta M., Harkins L.E., Gillespie G.Y., Merrick B.A., and MacMillan-Crow L.A. Evidence for peroxynitrite-mediated modifications to p53 in human gliomas: possible functional consequences. Arch Biochem Biophys 394 (2001) 167-172
42. Chazotte-Aubert L., Hainaut P., and Ohshima H. Nitric oxide nitrates tyrosine residues of tumor-suppressor p53 protein in MCF-7 cells. Biochem Biophys Res Commun 267 (2000) 609-613
43. MacMillan-Crow L.A., and Thompson J.A. Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite. Arch Biochem Biophys 366 (1999) 82-88
44. Robinson V.K., Sato E., Nelson D.K., Camhi S.L., Robbins R.A., and Hoyt J.C. Peroxynitrite inhibits inducible (type 2) nitric oxide synthase in murine lung epithelial cells in vitro. Free Radic Biol Med 30 (2001) 986-991
45. Lee C.I., Liu X., and Zweier J.L. Regulation of xanthine oxidase by nitric oxide and peroxynitrite. J Biol Chem 275 (2000) 9369-9376
46. MacMillan-Crow L.A., Crow J.P., and Thompson J.A. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 37 (1998) 1613-1622
47. Souza J.M., Choi I., Chen Q., Weisse M., Daikhin E., Yudkoff M., et al. Proteolytic degradation of tyrosine nitrated proteins. Arch Biochem Biophys 380 (2000) 360-366
48. Grune T., Blasig I.E., Sitte N., Roloff B., Haseloff R., and Davies K.J.A. Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome. J Biol Chem 273 (1998) 10857-10862
49. Gow A.J., Duran D., Malcolm S., and Ischiropoulos H. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett 385 (1996) 63-66
50. Grune T., Reinheckel T., and Davies K. Degradation of oxidized proteins in mammalian cells. FASEB J 11 (1997) 526-534
51. Reinheckel T., Sitte N., Ullrich O., Kuckelkorn U., Davies K.J.A., and Grune T. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J 335 (1998) 637-642
52. Jahngen-Hodge J., Obin M.S., Gong X., Shang F., Nowell Jr. T.R., Gong J., et al. Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J Biol Chem 272 (1997) 28218-28226
53. Glockzin S., von Knethen A., Scheffner M., and Brune B. Activation of the cell death program by nitric oxide involves inhibition of the proteasome. J Biol Chem 274 (1999) 19581-19586
54. Aulak K.S., Miyagi M., Yan L., West K.A., Massillon D., Crabb J.W., et al. Proteomic method identifies proteins nitrated in vivo during inflammatory challenge. Proc Natl Acad Sci U S A 98 (2001) 12056-12061
55. Saeki M., and Maeda S. p130cas is a cellular target protein for tyrosine nitration induced by peroxynitrite. Neurosci Res 33 (1999) 325-328
56. Pinzar E., Wang T., Garrido M.R., Xu W., Levy P., and Bottari S.P. Angiotensin II induces tyrosine nitration and activation of ERK1/2 in vascular smooth muscle cells. FEBS Lett 579 (2005) 5100-5104
57. Kiroycheva M., Ahmed F., Anthony G.M., Szabo C., Southan G.J., and Bank N. Mitogen-activated protein kinase phosphorylation in kidneys of beta(s) sickle cell mice. J Am Soc Nephrol 11 (2000) 1026-1032
58. Webster R.P., Brockman D., and Myatt L. Nitration of p38 MAPK in the placenta: association of nitration with reduced catalytic activity of p38 MAPK in pre-eclampsia. Mol Hum Reprod (2006)
59. Webster R.P., Macha S., Brockman D., and Myatt L. Peroxynitrite treatment in vitro disables catalytic activity of recombinant p38 MAPK. Proteomics 6 (2006) 4838-4844
60. Mallozzi C., Di Stasi A.M., and Minetti M. Peroxynitrite modulates tyrosine-dependent signal transduction pathway of human erythrocyte band 3. FASEB J 11 (1997) 1281-1290
61. Takakura K., Beckman J.S., MacMillan-Crow L.A., and Crow J.P. Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45, and LAR by peroxynitrite. Arch Biochem Biophys 369 (1999) 197-207
62. Klotz L.O., Schieke S.M., Sies H., and Holbrook N.J. Peroxynitrite activates the phosphoinositide 3-kinase/Akt pathway in human skin primary fibroblasts. Biochem J 352 Pt 1 (2000) 219-225
63. van der Vliet A., Hristova M., Cross C.E., Eiserich J.P., and Goldkorn T. Peroxynitrite induces covalent dimerization of epidermal growth factor receptors in A431 epidermoid carcinoma cells. J Biol Chem 273 (1998) 31860-31866
64. Uc A., Kooy N.W., Conklin J.L., and Bishop W.P. Peroxynitrite inhibits epidermal growth factor receptor signaling in Caco-2 cells. Dig Dis Sci 48 (2003) 2353-2359
65. Thomas S.M., and Brugge J.S. Cellular functions regulated by src family kinases. Annu Rev Cell Dev Biol 13 (1997) 513-609
66. Roskoski Jr. R. Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 331 (2005) 1-14
67. Lowell C.A. Src-family kinases: rheostats of immune cell signaling. Mol Immunol 41 (2004) 631-643
68. Pu M., Akhand A.A., Kato M., Hamaguchi M., Koike T., Iwata H., et al. Evidence of a novel redox-linked activation mechanism for the Src kinase which is independent of tyrosine 527-mediated regulation. Oncogene 13 (1996) 2615-2622
69. Mallozzi C., Di Stasi M.A., and Minetti M. Peroxynitrite-dependent activation of src tyrosine kinases lyn and hck in erythrocytes is under mechanistically different pathways of redox control. Free Radic Biol Med 30 (2001) 1108-1117
70. Mallozzi C., Di Stasi A.M., and Minetti M. Nitrotyrosine mimics phosphotyrosine binding to the SH2 domain of the src family tyrosine kinase lyn. FEBS Lett 503 (2001) 189-195
71. Kuo W.N., Kanadia R.N., Shanbhag V.P., and Toro R. Denitration of peroxynitrite-treated proteins by 'protein nitratases' from rat brain and heart. Mol Cell Biochem 201 (1999) 11-16
72. Kuo W.N., Kocis J.M., and Webb J.K. Protein denitration/modification by Escherichia coli nitrate reductase and mammalian cytochrome P-450 reductase. Front Biosci 7 (2002) 9-14
73. Low S.Y., Sabetkar M., Bruckdorfer K.R., and Naseem K.M. The role of protein nitration in the inhibition of platelet activation by peroxynitrite. FEBS Lett 511 (2002) 59-64
74. Koeck T., Fu X., Hazen S.L., Crabb J.W., Stuehr D.J., and Aulak K.S. Rapid and selective oxygen-regulated protein tyrosine denitration and nitration in mitochondria. J Biol Chem 279 (2004) 27257-27262
75. Khan F., and Ali R. Antibodies against nitric oxide damaged poly-l-tyrosine and 3-nitrotyrosine levels in systemic lupus erythematosus. J Biochem Mol Biol 39 (2006) 189-196
76. Khan F., and Siddiqui A.A. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus. Clin Chim Acta 370 (2006) 100-107
77. Hsu H.C., Zhou T., Kim H., Barnes S., Yang P., Wu Q., et al. Production of a novel class of polyreactive pathogenic autoantibodies in BXD2 mice causes glomerulonephritis and arthritis. Arthritis Rheum 54 (2006) 343-355
78. Augusto O., Bonini M.G., Amanso A.M., Linares E., Santos C.C., and De Menezes S.L. Nitrogen dioxide and carbonate radical anion: two emerging radicals in biology. Free Radic Biol Med 32 (2002) 841-859
79. Schopfer F.J., Baker P.R., and Freeman B.A. NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response?. Trends Biochem Sci 28 (2003) 646-654
80. Souza J.M., Daikhin E., Yudkoff M., Raman C.S., and Ischiropoulos H. Factors determining the selectivity of protein tyrosine nitration. Arch Biochem Biophys 371 (1999) 169-178
81. Landino L.M., Iwig J.S., Kennett K.L., and Moynihan K.L. Repair of peroxynitrite damage to tubulin by the thioredoxin reductase system. Free Radic Biol Med 36 (2004) 497-506
82. Neumann P., Gertzberg N., Vaughan E., Weisbrot J., Woodburn R., Lambert W., et al. Peroxynitrite mediates TNF-alpha-induced endothelial barrier dysfunction and nitration of actin. Am J Physiol Lung Cell Mol Physiol 290 (2006) L674-L684
83. Reynolds M.R., Reyes J.F., Fu Y., Bigio E.H., Guillozet-Bongaarts A.L., Berry R.W., et al. Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies. J Neurosci 26 (2006) 10636-10645
84. Oneda H., and Inouye K. Effect of nitration on the activity of bovine erythrocyte Cu, Zn-superoxide dismutase (BESOD) and a kinetic analysis of its dimerization-dissociation reaction as examined by subunit exchange between the native and nitrated BESODs. J Biochem 134 (2003) 683-690
85. Bartesaghi S., Ferrer-Sueta G., Peluffo G., Valez V., Zhang H., Kalyanaraman B., et al. Protein tyrosine nitration in hydrophilic and hydrophobic environments. Amino Acids 32 (2007) 501-515
86. Quijano C., Hernandez-Saavedra D., Castro L., McCord J.M., Freeman B.A., and Radi R. Reaction of peroxynitrite with Mn-superoxide dismutase. Role of the metal center in decomposition kinetics and nitration. J Biol Chem 276 (2001) 11631-11638
87. Cassina A.M., Hodara R., Souza J.M., Thomson L., Castro L., Ischiropoulos H., et al. Cytochrome c nitration by peroxynitrite. J Biol Chem 275 (2000) 21409-21415
88. Zou M.H. Peroxynitrite and protein tyrosine nitration of prostacyclin synthase. Prostaglandins Other Lipid Mediat 82 (2007) 119-127
89. Mehl M., Daiber A., Herold S., Shoun H., and Ullrich V. Peroxynitrite reaction with heme proteins. Nitric Oxide 3 (1999) 142-152
90. Bartesaghi S., Valez V., Trujillo M., Peluffo G., Romero N., Zhang H., et al. Mechanistic studies of peroxynitrite-mediated tyrosine nitration in membranes using the hydrophobic probe N-t-BOC-l-tyrosine tert-butyl ester. Biochemistry 45 (2006) 6813-6825
91. Elfering S.L., Haynes V.L., Traaseth N.J., Ettl A., and Giulivi C. Aspects, mechanism, and biological relevance of mitochondrial protein nitration sustained by mitochondrial nitric oxide synthase. Am J Physiol Heart Circ Physiol 286 (2004) H22-H29
92. Khalil R.A., Crews J.K., Novak J., Kassab S., and Granger J.P. Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats. Hypertension 31 (1998) 1065-1069
93. Barden A. Pre-eclampsia: contribution of maternal constitutional factors and the consequences for cardiovascular health. Clin Exp Pharmacol Physiol 33 (2006) 826-830
94. Williams D. Pregnancy: a stress test for life. Curr Opin Obstet Gynecol 15 (2003) 465-471
95. Newstead J., von Dadelszen P., and Magee L.A. Preeclampsia and future cardiovascular risk. Expert Rev Cardiovasc Ther 5 (2007) 283-294
96. Kossenjans W., Eis A., Sahay R., Brockman D., and Myatt L. Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. Am J Physiol Heart Circ Physiol 278 (2000) H1311-H1319
97. Roggensack A.M., Zhang Y., and Davidge S.T. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension 33 (1999) 83-89
98. Ray J. Metabolic syndrome and higher risk of maternal placental syndromes and cardiovascular disease. Drug Dev Res 67 (2006) 607-611
99. Adams R.H., Porras A., Alonso G., Jones M., Vintersten K., Panelli S., et al. Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 6 (2000) 109-116
100. Cindrova-Davies T., Spasic-Boskovic O., Jauniaux E., Charnock-Jones D.S., and Burton G.J. Nuclear factor-{kappa}B, p38, and stress-activated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress: effects of antioxidant vitamins. Am J Pathol 170 (2007) 1511-1520
101. Negash S., Gao Y., Zhou W., Liu J., Chinta S., and Raj J.U. Regulation of cGMP-dependent protein kinase-mediated vasodilation by hypoxia-induced reactive species in ovine fetal pulmonary veins. Am J Physiol Lung Cell Mol Physiol 293 (2007) L1012-L1020
102. Roberts V.H., Webster R.P., Brockman D.E., Pitzer B.A., and Myatt L. Post-translational modifications of the P2X(4) purinergic receptor subtype in the human placenta are altered in preeclampsia. Placenta 28 (2007) 270-277
103. Lanone S., Manivet P., Callebert J., Launay J.M., Payen D., Aubier M., et al. Inducible nitric oxide synthase (NOS2) expressed in septic patients is nitrated on selected tyrosine residues: implications for enzymic activity. Biochem J 366 (2002) 399-404
104. Carbillon L., Uzan M., and Uzan S. Pregnancy, vascular tone, and maternal hemodynamics: a crucial adaptation. Obstet Gynecol Surv 55 (2000) 574-581
105. Moncada S., and Vane J.R. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev 30 (1978) 293-331
106. Boulos C., Jiang H., and Balazy M. Diffusion of peroxynitrite into the human platelet inhibits cyclooxygenase via nitration of tyrosine residues. J Pharmacol Exp Ther 293 (2000) 222-229
107. Zou M., Martin C., and Ullrich V. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol Chem 378 (1997) 707-713
108. Wang Y.P., Walsh S.W., and Kay H.H. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. Am J Obstet Gynecol 167 (1992) 946-949
109. Salvemini D. Regulation of cyclooxygenase enzymes by nitric oxide. Cell Mol Life Sci 53 (1997) 576-582
110. Clancy R., Varenika B., Huang W., Ballou L., Attur M., Amin A.R., et al. Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production. J Immunol 165 (2000) 1582-1587
111. Remuzzi G., Marchesi D., Zoja C., Muratore D., Mecca G., Misiani R., et al. Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins 20 (1980) 105-110
112. Bachschmid M., Thurau S., Zou M.H., and Ullrich V. Endothelial cell activation by endotoxin involves superoxide/NO-mediated nitration of prostacyclin synthase and thromboxane receptor stimulation. FASEB J 17 (2003) 914-916
113. Klumpp G., Schildknecht S., Nastainczyk W., Ullrich V., and Bachschmid M. Prostacyclin in the cardiovascular system: new aspects and open questions. Pharmacol Rep 57 Suppl. (2005) 120-126
114. Redman C.W., Sacks G.P., and Sargent I.L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180 (1999) 499-506
115. Wolin M.S., Ahmad M., and Gupte S.A. The sources of oxidative stress in the vessel wall. Kidney Int 67 (2005) 1659-1661
116. Cuzzocrea S., Mazzon E., Dugo L., Di Paola R., Caputi A.P., and Salvemini D. Superoxide: a key player in hypertension. FASEB J 18 (2004) 94-101
117. van der Loo B., Koppensteiner R., and Luscher T.F. How do blood vessels age? Mechanisms and clinical implications. Vasa 33 (2004) 3-11
118. Miller Jr. F.J., Gutterman D.D., Rios C.D., Heistad D.D., and Davidson B.L. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82 (1998) 1298-1305
119. Wang Y., and Walsh S.W. Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta 19 (1998) 581-586
120. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
121. Stout A.K., Raphael H.M., Kanterewicz B.I., Klann E., and Reynolds I.J. Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat Neurosci 1 (1998) 366-373
122. Keller J.N., Kindy M.S., Holtsberg F.W., St Clair D.K., Yen H.C., Germeyer A., et al. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 18 (1998) 687-697
123. Kruman I., Guo Q., and Mattson M.P. Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells. J Neurosci Res 51 (1998) 293-308
124. Radi R., Cassina A., Hodara R., Quijano C., and Castro L. Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med 33 (2002) 1451-1464
125. MacMillan-Crow L.A., Crow J.P., Kerby J.D., Beckman J.S., and Thompson J.A. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci U S A 93 (1996) 11853-11858
126. Macmillan-Crow L.A., and Cruthirds D.L. Invited review: manganese superoxide dismutase in disease. Free Radic Res 34 (2001) 325-336
127. Pittman K.M., MacMillan-Crow L.A., Peters B.P., and Allen J.B. Nitration of manganese superoxide dismutase during ocular inflammation. Exp Eye Res 74 (2002) 463-471
128. van der Loo B., Labugger R., Skepper J.N., Bachschmid M., Kilo J., Powell J.M., et al. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 192 (2000) 1731-1744
129. Justilien V., Pang J.J., Renganathan K., Zhan X., Crabb J.W., Kim S.R., et al. SOD2 knockdown mouse model of early AMD. Invest Ophthalmol Vis Sci 48 (2007) 4407-4420
130. Jackson R.M., Helton E.S., Viera L., and Ohman T. Survival, lung injury, and lung protein nitration in heterozygous MnSOD knockout mice in hyperoxia. Exp Lung Res 25 (1999) 631-646
131. Ishihara N., Matsuo H., Murakoshi H., Laoag-Fernandez J.B., Samoto T., and Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 186 (2002) 158-166
132. Riobo N.A., Clementi E., Melani M., Boveris A., Cadenas E., Moncada S., et al. Nitric oxide inhibits mitochondrial NADH: ubiquinone reductase activity through peroxynitrite formation. Biochem J 359 (2001) 139-145
133. Murray J., Taylor S.W., Zhang B., Ghosh S.S., and Capaldi R.A. Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry. J Biol Chem 278 (2003) 37223-37230
134. Jekabsone A., Ivanoviene L., Brown G.C., and Borutaite V. Nitric oxide and calcium together inactivate mitochondrial complex I and induce cytochrome c release. J Mol Cell Cardiol 35 (2003) 803-809
135. Ray J.G., Vermeulen M.J., Schull M.J., McDonald S., and Redelmeier D.A. Metabolic syndrome and the risk of placental dysfunction. J Obstet Gynaecol Can 27 (2005) 1095-1101
136. Murphy V.E., Smith R., Giles W.B., and Clifton V.L. Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr Rev 27 (2006) 141-169
137. Hahn-Zoric M., Hagberg H., Kjellmer I., Ellis J., Wennergren M., and Hanson L.A. Aberrations in placental cytokine mRNA related to intrauterine growth retardation. Pediatr Res 51 (2002) 201-206
138. Coussons-Read M.E., Mazzeo R.S., Whitford M.H., Schmitt M., Moore L.G., and Zamudio S. High altitude residence during pregnancy alters cytokine and catecholamine levels. Am J Reprod Immunol 48 (2002) 344-354
139. Dandona P., Aljada A., Chaudhuri A., Mohanty P., and Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111 (2005) 1448-1454
140. Aronson D., Bartha P., Zinder O., Kerner A., Markiewicz W., Avizohar O., et al. Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obes Relat Metab Disord 28 (2004) 674-679
141. Catalano P., Hoegh M., Minium J., Huston-Presley L., Bernard S., Kalhan S., et al. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia 49 (2006) 1677-1685
142. Desoye G., and Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus: the insulin and cytokine network. Diabetes Care 30 (2007) S120-S126
143. Radaelli T., Varastehpour A., Catalano P., and Hauguel-de Mouzon S. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 52 (2003) 2951-2958
144. Paul-Clark M.J., Roviezzo F., Flower R.J., Cirino G., Soldato P.D., Adcock I.M., et al. Glucocorticoid receptor nitration leads to enhanced anti-inflammatory effects of novel steroid ligands. J Immunol 171 (2003) 3245-3252
145. Zamudio S., Kovalenko O., Vanderlelie J., Illsley N.P., Heller D., Belliappa S., et al. Chronic hypoxia in vivo reduces placental oxidative stress. Placenta 28 (2007) 846-853
146. Keshavarzian A., Banan A., Farhadi A., Komanduri S., Mutlu E., Zhang Y., et al. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 52 (2003) 720-728
147. Chevion M., Berenshtein E., and Stadtman E.R. Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic Res 33 Suppl. (2000) S99-S108
148. Uzun H., Konukoglu D., Gelisgen R., Zengin K., and Taskin M. Plasma protein carbonyl and thiol stress before and after laparoscopic gastric banding in morbidly obese patients. Obes Surg 17 (2007) 1367-1373
149. Zusterzeel P.L., Rutten H., Roelofs H.M., Peters W.H., and Steegers E.A. Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative stress. Placenta 22 (2001) 213-219
150. Dalle-Donne I., Rossi R., Giustarini D., Milzani A., and Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329 (2003) 23-38
151. Austin R.C., Lentz S.R., and Werstuck G.H. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 11 Suppl. 1 (2004) S56-S64
152. Dickhout J.G., Hossain G.S., Pozza L.M., Zhou J., Lhotak S., and Austin R.C. Peroxynitrite causes endoplasmic reticulum stress and apoptosis in human vascular endothelium: implications in atherogenesis. Arterioscler Thromb Vasc Biol 25 (2005) 2623-2629
153. 2+ pump isoforms SERCA2b and SERCA3a. Am J Physiol Cell Physiol 285 (2003) C1537-C1543
154. Kyuhou S.-i., Kato N., and Gemba H. Emergence of endoplasmic reticulum stress and activated microglia in Purkinje cell degeneration mice. Neurosci Lett 396 (2006) 91-96
155. Yamamuro A., Yoshioka Y., Ogita K., and Maeda S. Involvement of endoplasmic reticulum stress on the cell death induced by 6-hydroxydopamine in human neuroblastoma SH-SY5Y cells. Neurochem Res 31 (2006) 657-664
156. Yung H.-w., Korolchuk S., Tolkovsky A.M., Charnock-Jones D.S., and Burton G.J. Endoplasmic reticulum stress exacerbates ischemia-reperfusion-induced apoptosis through attenuation of Akt protein synthesis in human choriocarcinoma cells. FASEB J 21 (2007) 872-884
157. Webster R., Pitzer B.A., Roberts V.H.J., Brockman D., and Myatt L. Differences in the proteome profile in placenta from normal term and preeclamptic preterm pregnancies. Proteomics Clin Appl 1 (2007) 446-456
158. Duncan M.W. A review of approaches to the analysis of 3-nitrotyrosine. Amino Acids 25 (2003) 351-361
159. Samoszuk M., Brennan M.-L., To V., Leonor L., Zheng L., Fu X., et al. Association between nitrotyrosine levels and microvascular density in human breast cancer. Breast Cancer Res Treat 74 (2002) 271-278
160. Ghosh S., Janocha A.J., Aronica M.A., Swaidani S., Comhair S.A.A., Xu W., et al. Nitrotyrosine proteome survey in asthma identifies oxidative mechanism of catalase inactivation. J Immunol 176 (2006) 5587-5597
161. Shishehbor M.H., and Hazen S.L. Inflammatory and oxidative markers in atherosclerosis: relationship to outcome. Curr Atheroscler Rep 6 (2004) 243-250
162. Tabrizi-Fard M.A., Maurer T.S., and Fung H.L. In vivo disposition of 3-nitro-L-tyrosine in rats: implications on tracking systemic peroxynitrite exposure. Drug Metab Dispos 27 (1999) 429-431
163. Hoehn T., Janssen S., Mani A.R., Brauers G., Moore K.P., Schadewaldt P., et al. Urinary excretion of the nitrotyrosine metabolite 3-nitro-4 hydroxyphenylacetic acid in preterm and term infants. Neonatology 93 (2007) 73-76
164. Neumann H., Hazen J.L., Weinstein J., Mehl R.A., and Chin J.W. Genetically encoding protein oxidative damage. J Am Chem Soc 130 (2008) 4028-4033